» Articles » PMID: 29959665

Spherical Nucleic Acid Nanoparticles: Therapeutic Potential

Overview
Journal BioDrugs
Date 2018 Jul 1
PMID 29959665
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Spherical nucleic acids (SNAs) are highly oriented, well organized, polyvalent structures of nucleic acids conjugated to hollow or solid core nanoparticles. Because they can transfect many tissue and cell types without toxicity, induce minimum immune response, and penetrate various biological barriers (such as the skin, blood-brain barrier, and blood-tumor barrier), they have become versatile tools for the delivery of nucleic acids, drugs, and proteins for various therapeutic purposes. This article describes the unique structures and properties of SNAs and discusses how these properties enable their application in gene regulation, immunomodulation, and drug and protein delivery. It also summarizes current efforts towards clinical translation of SNAs and provides an expert opinion on remaining challenges to be addressed in the path forward to the clinic.

Citing Articles

Suppressed activation of the IRF7 and TLR9 by JAK2V617F gold nanoparticles.

Tokcan B, Demirtas E, Sozer S Immunogenetics. 2025; 77(1):16.

PMID: 40016346 PMC: 11868351. DOI: 10.1007/s00251-025-01374-y.


Photochemical Stabilization of Self-Assembled Spherical Nucleic Acids.

Kaviani S, Bai H, Das T, Asohan J, Elmanzalawy A, Marlyn J Small. 2025; 21(7):e2407742.

PMID: 39790078 PMC: 11840461. DOI: 10.1002/smll.202407742.


DENV Peptides Delivered as Spherical Nucleic Acid Constructs Enhance Antigen Presentation and Immunogenicity in vitro and in vivo.

Zhao J, He J, Ding X, Zhou Y, Liu M, Chen X Int J Nanomedicine. 2024; 19:9757-9770.

PMID: 39318604 PMC: 11421446. DOI: 10.2147/IJN.S467427.


Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer.

Dang M, Suri S, Li K, Casas C, Stigliano G, Riley R Adv Ther (Weinh). 2024; 7(6).

PMID: 39006318 PMC: 11238604. DOI: 10.1002/adtp.202300426.


Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.

Valatabar N, Oroojalian F, Kazemzadeh M, Mokhtarzadeh A, Safaralizadeh R, Sahebkar A J Nanobiotechnology. 2024; 22(1):386.

PMID: 38951806 PMC: 11218236. DOI: 10.1186/s12951-024-02648-5.


References
1.
Li Z, Jin R, Mirkin C, Letsinger R . Multiple thiol-anchor capped DNA-gold nanoparticle conjugates. Nucleic Acids Res. 2002; 30(7):1558-62. PMC: 101851. DOI: 10.1093/nar/30.7.1558. View

2.
Jiang W, Zhu F, Bhagat L, Yu D, Tang J, Kandimalla E . A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. J Invest Dermatol. 2013; 133(7):1777-84. DOI: 10.1038/jid.2013.57. View

3.
Alvarez-Salas L . Nucleic acids as therapeutic agents. Curr Top Med Chem. 2008; 8(15):1379-404. DOI: 10.2174/156802608786141133. View

4.
Banga R, Chernyak N, Narayan S, Nguyen S, Mirkin C . Liposomal spherical nucleic acids. J Am Chem Soc. 2014; 136(28):9866-9. PMC: 4280063. DOI: 10.1021/ja504845f. View

5.
Zelphati O, Wang Y, Kitada S, Reed J, Felgner P, Corbeil J . Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem. 2001; 276(37):35103-10. DOI: 10.1074/jbc.M104920200. View